Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients

Adult Antigens, Differentiation, T-Lymphocyte Male 0301 basic medicine Receptors, CCR7 Skin Neoplasms 610 Article 03 medical and health sciences CD57 Antigens Antigens, CD Humans Lectins, C-Type Melanoma Aged Middle Aged Receptors, Interleukin-6 CD56 Antigen 3. Good health Killer Cells, Natural Receptors, KIR2DL3 Lymphatic Metastasis Receptors, KIR2DL2 CD56(dim)KIR+CD57+;cytotoxic NK;cells ; tumour;melanoma;patients; Female Lymph Nodes
DOI: 10.1038/ncomms6639 Publication Date: 2014-12-04T11:26:53Z
ABSTRACT
An important checkpoint in the progression of melanoma is the metastasis to lymph nodes. Here, to investigate the role of lymph node NK cells in disease progression, we analyze frequency, phenotype and functions of NK cells from tumour-infiltrated (TILN) and tumour-free ipsilateral lymph nodes (TFLN) of the same patients. We show an expansion of CD56(dim)CD57(dim)CD69 + CCR7 +KIR+ NK cells in TILN. TILN NK cells display robust cytotoxic activity against autologous melanoma cells. In the blood of metastatic melanoma patients, the frequency of NK cells expressing the receptors for CXCL8 receptor is increased compared with healthy subjects, and blood NK cells also express the receptors for CCL2 and IL-6. These factors are produced in high amount in TILN and in vitro switch the phenotype of blood NK cells from healthy donors to the phenotype associated with TILN. Our data suggest that the microenvironment of TILN generates and/or recruits a particularly effective NK cell subset.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (122)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....